Scopolamine-induced impairment of delayed recognition of abstract visual shapes

Neuropsychobiology

Volumn 37, Issue 2, 1998, Pages 98-103

  Rosier, Annemie ^a,b   Cornette, Luc ^a   Orban, Guy A ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Long term memory; Recognition; Scopolamine; Vision shape

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; SCOPOLAMINE;

ADULT; ANTEROGRADE AMNESIA; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CLINICAL TRIAL; COGNITION; DRUG CLEARANCE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIMBIC SYSTEM; MALE; MEMORY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; VISUAL DISCRIMINATION; VISUAL MEMORY;

ADULT; COGNITION; FEMALE; FORM PERCEPTION; HUMANS; MALE; MEMORY; MUSCARINIC ANTAGONISTS; REACTION TIME; SCOPOLAMINE;

EID: 0031915220     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026486     Document Type: Article

References (24)

1. Dalmaz C, Introini-Collison IB, McGaugh JL: Noradrencrgic and cholinergic interactions in the amygdala and the modulation of memory storage. Behav Brain Res 1993;58:167-174.
2. Ennaceur A, Meliani K: Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests. Psychopharmacology 1992;109:321-330.
3. Ghoneim MM, Mewaldt SP: Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory. Psychopharmacology 1975;44:257-262.
4. Ghoneim MM, Mewaldt SP: Studies on human memory: The interactions of diazepam. scopolamine. and physostigmine. Psychopharmacology 1977;52:1-6.
5. Rupniak NMJ, Samson NA, Iversen SD: Induction of cognitive impairment by scopolamine and noncholinergic agents in rhesus monkeys. Life Sci 1991;48:893-899.
6. Rusted J, Eaton-Williams P: Distinguishing between attetional and amnestic effects in information processing: The separate and combined effects of scopolamine and nicotine on verbal free recall. Psychopharmacology 1991;104: 363-366.
7. Schifano F, Curran HV: Pharmacological models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on word valence rating, priming and recall. Psychopharmacology 1994;115:430-434.
8. Terry AV Jr, Buccafusco JJ, Jackson WJ: Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacol Biochem Behav 1993;45: 925-929.
9. Warburton DM, Rusted JM: Cholincrgic control of cognitive resources. Neuropsychobiology 1993;28:43-46.
10. Dawson GR, Iversen SD: The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behav Brain Res 1993;57: 143-153.
11. Yavich L, Sirvio J, Heinonen E, Rickkinen P: The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats. J Neurotransm 1993;6:189-197.
12. Rupniak NMJ, Field MJ, Samson NA, Steventon MJ, Iversen SD: Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models. Neurobiol Aging 1990;11:609-613.
13. Wesnes K, Warburton DM: Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology 1984;82:147-150.
14. Duka T, Curran HV, Rusted JM, Weingartner HJ: Perspectives on cognitive psychopharmacology research. Behav Pharmacol 1996;7: 401-410.
15. Hasselmo ME, Wyble BP, Wallenstein GV: Encoding and retrieval of episodic memories: Role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus 1996; 6:693-708.
16. Izquicrdo I, Medina JH, Bianchin M, Walz R, Zanatta MS, Da Silva RC, Silva MBE, Ruschel AC, Paczko N: Memory processing by the limbic system: Role of specific neurotransmitter systems. Behav Brain Res 1993;58:91-98.
17. Rosier A, Vogels R, Orban GA: Diazepam decreases performance in a long-term memory task using visual shapes. Neuroreport 1996;7: 1899-1904.
18. Zahn C, Roskies R: Fourier descriptors for plane closed curves. IEEE Trans Comp 1972; C21:269-281.
19. Vandenberghe R, Dupont P, Bormans G, Mortelmans L, Orban GA: Blood flow in human anterior temporal cortex decreases with stimulus familiarity. Neuroimage 1995;2:306-313.
20. Bond A, Lader M: The use of analogue scales in rating subjective feelings. Br J Med Psychol 1974;47:211-218.
21. Johnson KO: Sensory discrimination: Decision process. J Neurophysiol 1980;43:1771-1792.
22. Clark WG, Brater DC, Johnson AR: Cholinergic (muscarinic) blocking agents: in Bircher S (ed): Goth's Medical Pharmacology, ed 12. St. Louis, Mosby, 1988, p 835.
23. Ogawa M, Magata Y, Ouchi Y, Fukuyama H, Yamauchi H, Kimura J, Yonekura Y, Konishi J: Scopolamine abolishes cerebral blood flow response to somatosensory stimulation in anesthetized cats: PET study. Brain Res 1994;650: 249-252.
24. Blin J, Chase T: Effects of scopolamine on human brain glucose consumption. Neuropsychopharmacology 1995;12:273-274.